Skip to main content
. 2019 Jun 25;31(5):369–386. doi: 10.1089/ars.2018.7688

FIG. 10.

FIG. 10.

A proposed model for the cadioprotection of hESC-CVPCs in the mice model of acute MI. hESC-CVPCs implanted at acute phase of MI regulate immune regulatory activity, including the modulation of reparative macrophage polarization by activating STAT6 through at least secreted IL-4 and IL-13, which dominantly contributes to the cardioprotective effect of hESC-CVPCs in the infarcted hearts. hESC-CVPC, human embryonic stem cell-derived cardiovascular progenitor cell.